The latest trial published in the Scandinavian Journal of Rheumatology 2005 showed that 82% of patients reported a reduction in pain after 3 weeks of active treatment with GOPO®. Pain was alleviated to such an extent that 40% reduced their consumption of paracetamol³.
Further evidence of the effectiveness of GOPO® on chronic joint conditions has been reported in the Phytomedicine Journal 2004; 66% of patients taking GOPO® reported a reduction in joint pain. Interestingly, patients also reported an improvement in general wellbeing; including mood, sleep quality and energy.
